ELYSHA KACHEVAS: Open Payments
NPI 1023447539 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,783 in 127 payments from 26 companies in 2025. Trend: 2023 $3,656 · 2024 $3,992 · 2025 $2,783
Food & beverage: $2,783
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 39 | $821 |
| HARMONY BIOSCIENCES LLC | 11 | $309 |
| GlaxoSmithKline, LLC. | 24 | $282 |
| Inspire Medical Systems, Inc. | 2 | $206 |
| Verona Pharma, Inc. | 8 | $147 |
| GENZYME CORPORATION | 5 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $119 |
| Philips North America LLC | 4 | $100 |
| Grifols USA, LLC | 4 | $98 |
| Insmed, Inc. | 4 | $85 |
Products named: WAKIX, BREZTRI, FASENRA, INSPIRE, NUCALA, DUPIXENT, Ohtuvayre, AIRSUPRA.
Industry payments across MO — which companies pay providers there.
